Patents by Inventor Toni Jauset GONZÁLEZ

Toni Jauset GONZÁLEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for the treatment of cancer
    Patent number: 11427621
    Abstract: The invention relates to a polypeptide comprising or consisting of the polypeptide of SEQ ID NO: 1 wherein the residue X at position 89 of SEQ ID NO: 1 is not a cysteine, or a functionally equivalent variant of said polypeptide wherein the residue X at position 89 of SEQ ID NO: 1 is not a cysteine and their use in medicine, particularly in the prevention and/or treatment of cancer.
    Type: Grant
    Filed: July 17, 2017
    Date of Patent: August 30, 2022
    Assignees: INSTITUCIO CATALANA DE RECERCA I ESTUDIS AVANCATS, FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL HEBRON
    Inventors: Laura Soucek, Toni Jauset González, Marie-Eve Beaulieu
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
    Publication number: 20200247857
    Abstract: The invention relates to a polypeptide comprising or consisting of the polypeptide of SEQ ID NO: 1 wherein the residue X at position 89 of SEQ ID NO: 1 is not a cysteine, or a functionally equivalent variant of said polypeptide wherein the residue X at position 89 of SEQ ID NO: 1 is not a cysteine and their use in medicine, particularly in the prevention and/or treatment of cancer.
    Type: Application
    Filed: July 17, 2017
    Publication date: August 6, 2020
    Inventors: Laura Soucek, Toni Jauset Gonzàlez, Marie-Eve Beaulleu
  • Methods of treating fibrosis
    Patent number: 10226466
    Abstract: Disclosed are methods of treating fibrosis in a patient, comprising administering to a patient in need thereof a therapeutically effective amount of an ACK inhibitor (e.g., a BTK inhibitor, such as for example an irreversible BTK inhibitor, such as for example, ibrutinib).
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: March 12, 2019
    Assignee: Pharmacyclics LLC
    Inventors: Toni Jauset González, Daniel Massó-Vallés, Laura Soucek
  • METHODS OF TREATING FIBROSIS
    Publication number: 20180153896
    Abstract: Disclosed are methods of treating fibrosis in a patient, comprising administering to a patient in need thereof a therapeutically effective amount of an ACK inhibitor (e.g., a BTK inhibitor, such as for example an irreversible BTK inhibitor, such as for example, ibrutinib).
    Type: Application
    Filed: December 8, 2017
    Publication date: June 7, 2018
    Inventors: Toni Jauset González, Daniel Massó-Vallés, Laura Soucek
  • METHODS OF TREATING FIBROSIS
    Publication number: 20160199376
    Abstract: Disclosed are methods of treating fibrosis in a patient, comprising administering to a patient in need thereof a therapeutically effective amount of an ACK inhibitor (e.g., a BTK inhibitor, such as for example an irreversible BTK inhibitor, such as for example, ibrutinib).
    Type: Application
    Filed: December 2, 2015
    Publication date: July 14, 2016
    Inventors: Toni Jauset GONZÁLEZ, Daniel MASSÓ-VALLÉS, Laura SOUCEK